FDA Counsel.com 1 ANDAs, OTCs, Orphans and Cosmetics -- Key Issues Wednesday, August 18, 2004 SDRAN RAC STUDY COURSE Michael A. Swit, Esq. FDACounsel.com.
Experience with generic substitution of narrow therapeutic index (NTI) immunosuppressants Jens Heisterberg, Danish Medicines Agency Polish Presidency CHMP.
Supply Chain Management System Project The Partnership for Supply Chain Management March 2006.
